Mashaallah Yazdi; Majid Saffarinia; Hossein Zare
Abstract
Objective: Introduction: the aim of this study was to compare the efficacy of quality of life based therapy and emotion regulation therapy on biomarkers (HbA1C and blood glucose) in patients with type2 diabetes. Method: the present study was a quasi-experimental study with pretest-posttest design and ...
Read More
Objective: Introduction: the aim of this study was to compare the efficacy of quality of life based therapy and emotion regulation therapy on biomarkers (HbA1C and blood glucose) in patients with type2 diabetes. Method: the present study was a quasi-experimental study with pretest-posttest design and follow-up with control group. The study population consisted of patients with type 2 diabetes referred to Iranian hospital in Dubai. 45 patients were selected by convenience sampling and randomly assigned to two experimental and one control group. Training groups were treated based on quality of life and emotion regulation. Glycated hemoglobin and fasting blood glucose were measured before, after, and 6 months after the intervention. Findings: the results showed that treatment based on the quality of life and emotion regulation was effective on biomarkers in patients with type2 diabetes (). Comparison of the means of the two experimental groups showed that there was no significant difference between their effectiveness on HbA1C (P>0.05), but there was a significant difference between their effects on blood glucose levels at the posttest stage (P≤0.01). Conclusion: the results of this study showed the effect of quality of life therapy and emotion regulation on controlling blood glucose and HbA1C in patients with type2 diabetes.
